|1. Why is it important to sign a Copyright Transfer Agreement or Exclusive Licence?|
|2. My work is funded by the National Institutes of Health (NIH)|
|3. My work is funded by the Research Councils UK (RCUK)|
|4. My work is funded by the Wellcome Trust (WT)|
|5. What is OnlineOpen?|
|6. What are the permitted uses for OnlineOpen articles?|
|7. I am a UK government employee|
|8. I am a US federal government employee|
|9. I am another government employee|
|10. My employer holds the copyright|
|11. Special conditions relating to military personnel|
|12. What rights do I retain if I sign a Copyright Transfer Agreement (CTA)?|
|13. What sections must I sign?|
|14. Must all authors sign the Agreement?|
|15. Can I send a faxed or emailed copy of the Agreement?|
|16. Do all contributions require a signed Agreement?|
|17. What are the ‘Contributor representations’?||18. Do abstracts require an Agreement?|
|19. What about translations?||20. What do I do if some material has been published before?|
|21. I want to reproduce some figures/tables from an already published contribution|
|22. I want to reproduce some material from a website|
|23. Do I need permission to quote someone else’s work?|
|24. What is the situation regarding copyright in interviews?|
|25. What is the situation regarding plagiarism?|
|26. What is the situation regarding retractions?|
|27. What is the situation regarding dual publication?||28. Can you provide advice regarding libel and slander?|
It is a legal requirement for Wiley to receive either a signed Copyright Transfer Agreement (CTA) or an Exclusive Licence Agreement (ELA) before publication of your contribution can proceed. Wiley has adopted the CTA for all Wiley-owned journals. For society-owned journals, the societies for whom we publish decide which versions of the forms they require.
This policy also has the following advantages:
Sample copyright forms are provided via the following links:
These agreements supersede prior versions. Authors who signed agreement forms prior to January 1, 2014 will still be able to archive their articles as outlined in Wiley's current Terms and Conditions for Self-Archiving.
Further to the NIH mandate, Wiley will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see http://authorservices.wiley.com/bauthor/onlineopen.asp.
You must comply with the terms of the RCUK's mandate which came into effect on 1 April 2013 and ensure your article is published Open Access (see http://authorservices.wiley.com/bauthor/onlineopen.asp). If you elect to pay to make your article OnlineOpen, you will be asked to sign the Creative Commons Attribution (CC-BY) licence, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. This will be reflected in the copyright statement that accompanies the published version of the article. See http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html for more information relating to the Creative Commons licences used for Wiley Open Access articles'
You must comply with the terms of the Wellcome Trust’s mandate which came into effect on 1 April 2013 and ensure your article is published Open Access (see http://authorservices.wiley.com/bauthor/onlineopen.asp). If you elect to pay to make your article OnlineOpen, you will be asked to sign the Creative Commons Attribution (CC-BY) licence, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. This will be reflected in the copyright statement that accompanies the published version of the article. See http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html for more information relating to the Creative Commons licences used for Wiley Open Access articles.
OnlineOpen is a service offered by Wiley that enables authors the opportunity to ensure that their final published contribution is made available for anyone to access online. This option is an important part of Wiley's response to the calls for open access and our commitment to viable high-quality publishing on behalf of societies.
For further details, please see http://authorservices.wiley.com/bauthor/onlineopen.asp.
Authors who elect to make their article OnlineOpen are invited to sign one of three Creative Commons Licences: the Creative Commons Attribution Licence (CC-BY), the Creative Commons Attribution Non-Commercial Licence (CC-BY-NC) and the Creative Commons Attribution Non-Commercial No Derivatives Licence (CC-BY-NC-ND). Further information about these licences, and the permitted uses, can be found at: http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html
Sample copies of these licences can be found at:
The rights in a contribution prepared by an employee of a UK government department, agency or other Crown body as part of his/her official duties, or which is an official government publication, belong to the Crown. Authors must ensure they comply with departmental regulations and submit the appropriate authorization to publish.
A contribution prepared by a US federal government employee as part of the employee's official duties, or which is an official US government publication, is called a ‘US Government work’, and is in the public domain in the United States. If the contribution was not prepared as part of the employee's duties or is not an official US government publication, it is not a US Government work. In the case of a contribution prepared under US government contract or grant, the US government may reproduce, without charge, all or portions of the contribution and may authorize others to do so, for official US government purposes only, if the US government contract or grant so requires.
If you are employed by the Department of Veterans Affairs in Australia, the World Bank, the International Monetary Fund, the European Atomic Energy Community, the Jet Propulsion Laboratory at California Institute of Technology, or are a Canadian Government civil servant, please download a copy of the relevant license agreement below:
Where work is carried out by an author in their capacity as an employee of a company, copyright will be owned by the company. An authorized signatory of the company must therefore sign the Agreement.
If you are an employee of Amgen, please download a copy of the company addendum from the link below and return your signed license agreement along with the addendum:
Work carried out by government employees or military personnel may require a statement to the effect that the opinions expressed do not necessarily reflect those of the military or government agency for which they work. Please ensure that you check with the appropriate authorities and include the necessary statement within the body of your contribution. (See also section 7 'I am a UK government employee' or section 8 'I am a US federal government employee'.)
The Contributor or, if applicable, the Contributor's Employer, retains all proprietary rights other than copyright, such as patent rights, in any process, procedure or article of manufacture described in the contribution.
Contributors may re-use unmodified abstracts for any non-commercial purpose. For online use of the abstract, Wiley encourages but does not require linking back to the final published contribution.
Contributors may use the articles in teaching duties and in other works such as theses.
Contributors may re-use figures, tables, data sets, artwork, and selected text up to 250 words from their contributions without seeking permission, provided the following conditions are met:
Additional re-use rights are set forth in the actual copyright Agreement.
You must sign in the space indicated depending on whether you own the copyright in your work, the copyright is owned by your employer or whether you are a government employee. It is essential to check that the CTA or ELA (the Agreement) has been completed, signed and dated correctly before your contribution can be published.
Ideally, all authors should sign the Agreement, with additional signatures attached separately if necessary. However, if it is not possible to obtain a physical signature from all authors, you must have their agreement in writing to enable you to enter into the Agreement on their behalf.
Wiley will accept faxes, as well as scanned copies of the signed original forms via e-mail.
Yes, signed forms are required for all contribution types (apart from letters and correspondence).
In signing the forms you confirm that:
Meetings abstracts. We do not require a signed Agreement to publish abstracts of material submitted for poster sessions and presentations at conferences or meetings. The right to publish such material is presumed.
Abstracts specifically created for abstract publications. If you have written an abstract of a previously published article for publication in another journal (e.g. a reviews-type journal), we do require you to sign an Agreement.
Reproduction of existing abstracts. If you wish to include verbatim abstracts from previously published articles, you do not need written permission from the publisher of those articles, although the source should be cited. Abstracts are covered by copyright and are not in the public domain but there is an exception in UK law which permits the copying and publication of scientific and technical abstracts accompanying published periodical articles.
Let's say, for example, that you have published an article in Spanish by Palabra Publications. You have translated the article yourself (or by employing a translator) and want to submit the English translation to a Wiley journal, say Journal of Indelible Research.
In order to make the translation, you must first approach Palabra for permission to translate the article for republication. The translation itself would then be held under separate copyright – by you or the translator. You would then be able to sign the Journal of Indelible Research Copyright Transfer Agreement for the translation, rather than the original article.
The translation must include a full bibliographic reference to the original publication and you must have obtained permission from the original copyright holder to make the translation.
The corresponding author is responsible for obtaining written permission to reproduce the material "in print and other media" from the publisher of the original source, and for supplying Wiley with that permission. A RightsLink facility for requesting permission from Wiley journals is available on each journal's website. The corresponding author is also responsible for completing and returning to the editorial office or the publisher the journal-specific copyright transfer form, and any financial disclosure forms that might be required for a particular journal. These forms are found via the Wiley Author Licensing Service or on each journal's website. Forms may also be available from the journal's editorial office.
Following is more information to help you obtain necessary written permissions.
Author retains copyright: If you, the author, have retained the copyright, it is still likely that the first journal will have required an exclusive licence to publish, which means that you are not in a position to authorize another journal to republish. As a general rule it is essential to obtain written permission from the original publisher or society to reproduce the relevant material if this is not made clear in the Agreement or licence you signed for that publisher or society. It will always be necessary to seek permission to re-publish unless the licence you have signed is clearly for non-exclusive rights only.
Copyright rests with the original publisher: Where the previous publisher owns the copyright, the copyright line on the re-published contribution should refer to the previous publisher. In these cases the copyright line that will appear on the published contribution will be e.g., © 2013 Oxford University Press.
Copyright is owned by a third party: If content has been previously published, and a third party is the copyright holder or exclusive licensee of rights in that material, you must seek and obtain permission for re-use, and credit the material in accordance with the permission grant. This applies whether you have written the material yourself or whether it has been written by a third party. Permission is generally not required for brief and insubstantial extracts of text or references to other works, provided that these are properly attributed. In all cases, you should be aware that duplicate publication can constitute an infringement and/or an ethical violation if it is not made clear that the material has been published before.
You must ensure that you have received permission from the copyright holder or exclusive licensee to reproduce in the contribution all material not owned by you, and that you have provided full acknowledgement of the source. In most cases, the original publisher's Rights Department or the journal editorial office will advise you of the exact form of words required. This usually includes a full bibliographic reference to the original publication, and an acknowledgement that the material is reproduced with permission from the rights owner.
Wiley is a signatory to an agreement signed by the majority of scientific, technical and medical (STM) publishers whereby participating publishers do not make reciprocal charges for the reproduction of copyright material. (For further information, please see the Permission Guidelines at : http://www.stm-assoc.org.) These guidelines extend to re-use of a small number of figures and tables from journal articles without seeking permission and a number of large STM publishers have signed up to this.
Just because material is freely available on the web, it does not necessarily mean that the information can be reproduced without permission. We recommend the following actions:
If the website has posted material without seeking permission from the copyright holder and/or the source is unknown, then you are taking a risk in including the material in your work. As a last resort, the Authors' Licensing and Collecting Society (ALCS) can be contacted to trace the copyright holder: http://www.alcs.co.uk.
Fair use or fair dealing (depending on the country whose laws apply) allow use of a copyrighted work for the purposes of criticism or review. This extends to quotations that form part of book reviews and other critical material. Permission to quote is not required in such instances, provided the extracts are not substantial and are genuinely required for the purposes of review or criticism. For works of shorter length, such as songs, permission to re-use shorter extracts may be required. All sources must be credited – title and author at minimum – in order for fair dealing to apply.
If the record of an informal conversation you held with a particular interviewee appears in a contribution there is no issue regarding copyright. However, copyright may rest with the interviewee in cases of formal interviews where you record the subject's conversation on a tape recorder or verbatim. It is therefore necessary for the interviewee to sign the Agreement.
In some cases, copyright in interviews is shared jointly between interviewer and interviewee where the conversation being recorded represents a mutual exchange between the two. In such cases both parties should sign the Agreement.
The Contributor’s representations contained in the Agreement are designed to protect against plagiarism.
Wiley policy is based on the 'Guidelines on Good Publication Practice' published by the Committee on Publication Ethics (COPE) and can be found at http://authorservices.wiley.com/bauthor/publicationethics.asp.
COPE defines plagiarism as follows:
'Plagiarism ranges from the unreferenced use of others' published and unpublished ideas, including research grant applications, to submission under 'new' authorship of a complete paper, sometimes in a different language. . . It applies to print and electronic versions.'
Dealing with misconduct
It is the duty of journal editors to investigate suspected cases of misconduct. They need to decide whether it is necessary to retract a published contribution and in some cases, whether it is necessary to alert the employers of the accused author(s). Some evidence is required, but if the employers have a process for investigating accusations, it is not necessary for the editor to assemble a complete case as this may entail wider consultation which would bring the author into disrepute before the facts of the matter have been decided.
Editors may decide not to involve employers in cases of less serious misconduct, such as dual publication, deception over authorship or failure to declare a conflict of interest. In all cases, authors must be given the opportunity to respond to accusations of misconduct before any action is taken. (See http://authorservices.wiley.com/bauthor/faq_main.asp).
The following sanctions are set out in the COPE guidelines, but journal editors should consider the application of any sanction very seriously due to the potential impact on an author’s reputation or career. The COPE guidelines have no legal force and it is generally prudent to avoid ‘naming and shaming’ authors and simply to confirm a retraction, when necessary, in neutral and concise terms.
It is Wiley policy strongly to discourage withdrawal of an article in line with the STM guidelines on retractions: 'Preservation of the Objective Record of Science - an STM Guideline' (http://www.stm-assoc.org).
The practice of removal, deletion or obscuring of an article or portion thereof should be limited to circumstances such as:
Even in these circumstances, bibliographic information about the removed contribution should be retained for the scientific record, and an explanation given, however, brief, about the circumstances of its removal.
For most cases of infringement, Wiley recommends linking a retraction statement to the article in question, while retaining the article as first published in order to maintain the scientific record.
Dual publication of an article is generally not permitted. In signing the Agreement you are being asked to represent that the contribution has not been submitted elsewhere for publication. There are narrow exceptions to the dual publication rule for some materials, such as standards. In any such case, prior approval from the journal to which you are submitting is likely to be required.
Libel and slander are both forms of defamation and so in defining them it is necessary to look at what is meant by defamation. Broadly, defamation arises where a statement is made which is false and which impugns another person's reputation, or adversely affects his or her standing in the community.
Libel can be defined as a statement in print, or some other permanent form, concerning any person, which exposes that person to hatred, or ridicule, or which might injure that person in their profession, trade or calling. In the UK, the printer, publisher and author may all be held liable for libelous statements in printed published form. Ignorance is not an acceptable defence . . .
The difference between libel and slander relates to how the defamatory statement is made. In libel, the defamatory statement is expressed in a permanent and visual form including written words and printed images. In slander, the defamatory statement is in a transient form, conveyed for example by spoken words or gestures.
There is a range of defences to an action for libel. In the UK, the two main defences (apart from 'privilege') are 'justification' and 'fair comment'. In a defence of justification it must be established that the works in question are true in substance and in fact. In a defence of fair comment, which only protects statements of opinion, the defence is that the words in questions are a comment – based on actual facts – on a matter of public interest and are not malicious. Laws in other countries differ, but truth is always a defense. If in any doubt, please refer to Wiley for guidance.
If you are interested in submitting a manuscript, view the author guidelines for each journal by selecting the journal title below (the guidelines will appear in a new browser window):